beta cells
Showing 1 - 25 of >10,000
Visualizing Beta Cells After Bariatric Surgery
Recruiting
- Type 2 Diabetes Mellitus
- 68Ga-exendin PET/CT
-
Arnhem, Gelderland, Netherlands
- +1 more
Jun 16, 2022
Pancreatic Calcium Handling in Islet Beta Cells in Type 1
Completed
- Type 1 Diabetes
-
Edinburgh, Scotland, United KingdomUniversity of Edinburgh
Mar 25, 2022
Pancreatic Islets in Patients Undergoing Pancreatectomy
Recruiting
- Diabetes Mellitus
- No intervention
-
Düsseldorf, NRW, GermanyGerman Diabetes Center
Nov 27, 2023
Visualizing Beta Cells After Islet Transplantation
Terminated
- Type 1 Diabetes Mellitus
- 68Ga-NODAGA-exendin PET/CT
-
Nijmegen, Gelderland, Netherlands
- +1 more
Jan 29, 2022
Transfusion-dependent Beta-Thalassemia Trial in Peshawar (Thalidomide)
Completed
- Transfusion-dependent Beta-Thalassemia
-
Peshawar, Khyber Pakhtunkhwa, PakistanBlood Care Clinic
Nov 19, 2023
Obesity, Hypoglycemia Post Gastric Bypass Surgery, Hyperinsulinemic Hypoglycemia Trial in Arnhem (GLP-1R PET)
Recruiting
- Obesity
- +2 more
- GLP-1R PET
-
Arnhem, NetherlandsRijnstate hospital
Oct 27, 2022
Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T
Not yet recruiting
- Multiple Myeloma
- BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
- +3 more
- (no location specified)
Jul 28, 2023
ß-thalassemia Trial (BD211)
Not yet recruiting
- β-thalassemia
- BD211
- (no location specified)
Mar 15, 2023
Diabetes, Type 1 Trial in Warsaw (Phenofibrate, Placebo)
Recruiting
- Diabetes Mellitus, Type 1
- Phenofibrate
- Placebo
-
Warsaw, Mazowieckie, Poland
- +1 more
Jun 8, 2023
Thalassemia, Beta, Thalassemia Major Trial in Tianjin (VGB-Ex01)
Not yet recruiting
- Thalassemia, Beta
- Thalassemia Major
- VGB-Ex01
-
Tianjin, Tianjin, ChinaRegenerative Medicine Center
Sep 11, 2023
Gestational Diabetes Trial in Nijmegen (68Ga-NODAGA-exendin-4 PET/CT)
Recruiting
- Gestational Diabetes
- 68Ga-NODAGA-exendin-4 PET/CT
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Jun 15, 2021
Immunodeficiencies, Immune Dysregulation Syndromes Trial in Philadelphia (Apha/beta T and CD19+ cell depletion using CliniMACS
Recruiting
- Immunodeficiencies
- Immune Dysregulation Syndromes
- Apha/beta T and CD19+ cell depletion using CliniMACS device
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Nov 8, 2022
ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)
Recruiting
- β-thalassemia
- β-globin restored autologous hematopoietic stem cells
-
Shenzhen, Guangdong, ChinaShenzhen Children's Hospital
Feb 24, 2023
Anatomic Stage IV Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Anatomic Stage IV Breast Cancer AJCC v8
- HER2-Negative Breast Carcinoma
- Biospecimen Collection
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 30, 2023
Pediatric Brain Tumor, Recurrent Pediatric Brain Tumor, Pediatric Supratentorial Tumor Trial in San Francisco (Universal Donor
Not yet recruiting
- Pediatric Brain Tumor
- +2 more
- Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
- Implantation
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 24, 2023
Ovarian Function Insufficiency, Fertility Issues, Infertility,Female Trial in Abu Dhabi (Follitropin beta injection 150 IU,
Not yet recruiting
- Ovarian Function Insufficiency
- +3 more
- Follitropin beta injection 150 IU
- Follitropin beta injection 300 IU
-
Abu Dhabi, United Arab EmiratesART Fertility Clinics LLC
Feb 1, 2023
ß-thalassemia Trial in Shanghai (BD211)
Not yet recruiting
- β-thalassemia
- BD211
-
Shanghai, ChinaShanghai Ruijin Hospital
Mar 16, 2023
Alzheimer Trial (ALZN002 (autologous DCs pulsed with E22W mutant peptide)., Placebo)
Not yet recruiting
- Alzheimer Disease
- ALZN002 (autologous DCs pulsed with E22W mutant peptide).
- Placebo
- (no location specified)
Apr 17, 2023
Acute Biphenotypic Leukemia, Acute Myeloid Leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in
Recruiting
- Acute Biphenotypic Leukemia
- +13 more
- Cladribine
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jan 19, 2023
Beta-Thalassemia Trial in Nanning (CS-101)
Recruiting
- Beta-Thalassemia
- CS-101
-
Nanning, ChinaThe First Affiliated Hospital of Guangxi Medical University
Sep 9, 2023
Merkel Cell Polyomavirus Infection, Stage IV Merkel Cell Carcinoma AJCC v7 Trial in Seattle (drug, other, biological, radiation)
Terminated
- Merkel Cell Polyomavirus Infection
- Stage IV Merkel Cell Carcinoma AJCC v7
- Avelumab
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Feb 25, 2022
Transfusion Dependent Beta Thalassemia, Hemoglobinopathies, Thalassemia Major Trial in Nashville (EDIT-301)
Recruiting
- Transfusion Dependent Beta Thalassemia
- +3 more
- EDIT-301
-
Oakland, California
- +3 more
Jan 3, 2023
HER2+ Advanced Breast Cancer, Other Solid Tumors Trial (ADCC-R-Epo-R T-cells + Trastuzumab, Erythropoietin beta, Fludarabine and
Not yet recruiting
- HER2+ Advanced Breast Cancer
- Other Solid Tumors
- ADCC-R-Epo-R T-cells + Trastuzumab
- +2 more
- (no location specified)
Aug 31, 2023
ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)
Recruiting
- β-thalassemia
- β-globin restored autologous hematopoietic stem cells
-
Shenzhen, Guangdong, ChinaShenzhen University General Hospital
May 8, 2023
Study of Autoimmune Lymphoproliferative Syndrome (ALPS)
Recruiting
- Benign Lymphoproliferative Disorder
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023